Table 2.
(ABC) Microbial findings in BALF during first year expressed as total number of patients (percent of patients, n total=126). Owing to bronchoscopies with several microbiological findings the figures do not sum up to 100%
| n patients (% patients) | |
|---|---|
| A. Bacteria | |
| Gram‐negative | |
| Pseudomonas aeruginosa | 36 (29) |
| Stenotrophomonas | 16 (13) |
| Escherichia coli | 10 (8) |
| Achromobacter | 4 (3) |
| Moraxella catarrhalis | 3 (2) |
| Chryseobacterium | 2 (2) |
| Serratia | 2 (1) |
| Other Gram‐negative | 5 (3) |
| Gram‐positive | |
| Staphylococcus aureus | 22 (17) |
| Coagulase negative staphylococcus | 25 (20) |
| Enterococcus | 8 (6) |
| Enterobacter | 6 (3) |
| Staphylococcus lugdunensis | 2 (2) |
| Pneumococcus | 2 (2) |
| Mycobacterium tuberculosis | 1 (1) |
| Mycobacterium abscessus | 1 (1) |
| B. Fungi | |
| Yeast | |
| Candida albicans | 42 (33) |
| Candida non‐albicans | 17 (13) |
| Mold | |
| Aspergillus fumigatus | 21 (17) |
| Aspergillus non‐fumigatus | 15 (12) |
| Fusarium | 3 (2) |
| Penicillium | 11 (9) |
| Other mold | 3 (2) |
| Pneumocystis a | 5 (3) |
| C. Virus | |
| Coronavirus | 10 (8) |
| Rhinovirus | 9 (7) |
| Parainfluenza virus | 4 (3) |
| Metapneumovirus | 3 (2) |
| Herpes simplex virus 1 | 2 (2) |
| Respiratory syncytial virus | 2 (2) |
| Adenovirus | 2 (2) |
| Other virus | 3 (2) |
a
Positive in PCR (no sample positive in IF).
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.